Loading...
Loading...
Contributors:
Dataset URI:
94e05fd3-f034-4a2a-a9a4-748bde28ed06The purpose of the study is to develop a 20% subcutaneous immunoglobulin treatment option for patients with primary immunodeficiency (PID) diseases.
Keyword(s):
Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin); Immune Globulin Intravenous (Human), 10%; Immune Globulin Subcutaneous (Human); Immune Globulin Subcutaneous (Human), 20%; Immunoglobulins, Normal Human.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)